Member Info for Alwaysone

What market? Loads, including the UK and more importantly, the US, who have recently said they don't want to use imported stuff as many can't be trusted, but GDR already have connections and agreement on Pathogen detection (DoD) with the US Department of Defense
------------------------------
The Company has now received confirmation that a long-term supply contract with the US Department of Defense
(“DoD”) will be agreed that will enable ordering Pathogen detection (DoD)

I'm not selling, said a few days ago, dips happened on all the best stocks ( like NCYT) I sold out too early on and not doing it here this time, in for the longer, higher prices. AVCT down 9% so far, so nearly a sector thing maybe.
Amazing how we're in for the worst economy/recession for many years and the markets still up and bullish, trading often makes no sense!

The MM shake out I mentioned last night and earlier, was always inevitable, share never go up in a straight line. The holders win long term of course if you look at all the other virus shares. Plus always try and buy on any dip! dyor

I still think we might get a pullback this afternoon after the great run we've had since last week, the RSI is high...could be totally wrong though and it flies up again! HEMO still flying, wish had enough money to be in both but this one is the best of all of them longer term and similar to NCYT chart rise imho

It’s good to see some if the 20p-30p buyers selling out or top slicing I think. Then see next leg up.

I do agree with more liquidity to attract more big investors in.

Looks like could sail through £1.50 today. Imagine price with an RNS!! It will rocket

15% already, the word is out on where it be!

Coldspy, looks like you might be right. The other testing shares opened up down, maybe moving here!

I hope £1.50 but have a feeling that without an RNS, there could be a small MM pullback. Kind of thing they do of course but all guesswork as the impetus is upwards for sure.

The point if AVCT that put me off a bit but maybe it shouldn’t have, is the recent 18p placing. Such a huge discount to current price. Really like the test concept though.

the Company has today conditionally raised gross proceeds of £3.75 million pursuant to a placing (the "Placing") through the issuance of 20,833,333 new ordinary shares ("Ordinary Shares") at a price of 18 pence per share, being the same price as the Subscription.

Peel Hunt upbeat
In a note to clients, analysts at Peel Hunt repeated their 'buy' rating on Genedrive shares and noted that the important feature of Genedrive’s 96 SARS-CoV-2 assay is that - when combined with Cytiva’s stabilisation technology - the assay lends itself to extreme, high-throughput, with the potential of manufacturing over 10,000 tests per hour in a 96-well, temperature-stable plate-format that could be transported globally without the requirement of refrigeration.

They said: "We share the company view that PCR testing for coronavirus will be required in huge numbers for the foreseeable future."

The analysts added: "As a reminder, this is only one of the two assay programmes that the company is pursuing/progressing (in relation to coronavirus) as announced on 25th March. Given the company’s focus on these assays/recent developments – and their exciting potential – we now put our TP/forecasts under review until the company has had chance to crystallise this opportunity."

Just as a reminder for any potential new investors ( should be plenty of them!) It seems these should be ready in 4 weeks now ( this as week ago) unless we have an update RNS that states even sooner....

it has agreed a collaboration deal with Cytiva to develop the Genedrive 96 SARS-CoV-2 assay for use on lab-based polymerase chain reaction (PCR) instruments which could see a test for coronavirus (COVID-19) available within five weeks.
The AIM-listed molecular diagnostics specialist said the project with Cytiva - the company formerly known as GE Healthcare Life Sciences - is one of two assay programmes it is developing as per its coronavirus test announcement late last month.
The Genedrive 96 SARS-CoV-2 assay combines Genedrive's PCR chemistry integrated with Cytiva's LyoStable stabilisation technology. The combination would allow for high throughput manufacturing of over 10,000 tests per hour in a 96-well, temperature-stable plate format that could be transported globally without the need for refrigeration.

"We have extensive experience working with the Cytiva team on assay development and manufacturing for our Point of Care HCV [hepatitis C virus], AIHL [antibiotic induced hearing loss], and military programmes,” said David Budd, the chief executive officer of Genedrive in a statement.

“We are pleased to now apply that partnership in a high throughput manufacturing process, which we believe places us amongst a small group of companies that have the capability to produce simple assay solutions at significant scale. We are working very aggressively and plan to have product available in the next five weeks,” Budd added.

Gabriel Fernandez de Pierola, the general manager of Genomics and Diagnostics at Cytiva, said the spread of the SARS-COV-2 virus is driving an urgent need for extensive testing, particularly among patients and health workers.

“Critical to overcoming the pandemic is being able to produce high volumes of reliable tests which can be shipped easily on a global basis with minimal environmental impact. We hope our Lyo-Stable technology coupled with Genedrive's high throughput testing solution will help deliver technical solutions to address the current crisis," he said.

Final push for the day??

The US and Dow might puch this even further up in the next two hours, let's see.....

I think we might finish at £1.10ish today but would love to see it try and crack £1.20

Just read Hemo and the mice etc, does sound good - could have bought at 2.5p last Thursday - it;s still rising, crazy sector, some people must be making a fortune - anyway, back to where I'm still keeping all my money GDR and go with what I know

I missed HEMO as well, never heard of them before. Can't be on every share eh!

Just ignore him, I am from now on, he is clearly bored and on here to wind up everyone - not heard of a share price breather - sigh

You guys are having a great day today....well done ;) GDR also at 30% plus, this sector is mental!!